Oxidative stress and the pathogenesis of muscular dystrophies

American Journal of Physical Medicine and Rehabilitation

Volumn 81, Issue 11 SUPPL., 2002, Pages

  Rando, Thomas A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell death; Dystroglycan; Dystrophin; Free radical; Glutathione; Glutathione peroxidase; Muscle; Superoxide dismutase

Indexed keywords

DISEASES; GENES; MUSCLE; PATHOLOGY;

PATHOGENESIS;

PATIENT REHABILITATION;

ANTIOXIDANT; ASCORBIC ACID; DYSTROGLYCAN; DYSTROPHIN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; PENICILLAMINE; SUPEROXIDE DISMUTASE; TOCOPHEROL;

ANTIOXIDANT ACTIVITY; CELL DEATH; CLINICAL TRIAL; CONFERENCE PAPER; DUCHENNE MUSCULAR DYSTROPHY; GENETIC DISORDER; HUMAN; MUSCLE ATROPHY; MUSCLE NECROSIS; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS;

APOPTOSIS; DYSTROPHIN; HUMANS; MEMBRANE GLYCOPROTEINS; MUSCLE FIBERS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NECROSIS; OXIDATIVE STRESS;

EID: 0036838245     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200211001-00018     Document Type: Conference Paper

References (109)

1. Cohn RD, Campbell KP: Molecular basis of muscular dystrophies. Muscle Nerve 2000;23:1456-71
2. Emery AEH: Duchenne Muscular Dystrophy, New York, Oxford University Press, 1993
3. Allamand V, Campbell KP: Animal models for muscular dystrophy: Valuable tools for the development of therapies. Hum Mol Genet 2000;9:2459-67
4. Sicinski P, Geng Y, Ryder-Cook AS, et al: The molecular basis of muscular dystrophy in the mdx mouse: A point mutation. Science 1989;244:1578-80
5. Bulfield G, Siller WG, Wight PA, et al: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-92
6. McArdle A, Edwards RH, Jackson MJ: How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromuscul Disord 1995;5:445-56
7. Rando TA: The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 2001;24:1575-94
8. Turner PR, Westwood T, Regen CM, et al: Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 1988;335:735-8
9. Vrbova G: Duchenne dystrophy viewed as a disturbance of nerve-muscle interactions. Muscle Nerve 1983;6:671-5
10. Murphy ME, Kehrer JP: Free radicals: A potential pathogenic mechanism in inherited muscular dystrophy. Life Sci 1986;39:2271-8
11. Engel WK: Duchenne muscular dystrophy: A histologically based ischemia hypothesis and comparison with experimental ischemia myopathy, in Pearson CM, Mostofi FK (eds): The Striated Muscle. Baltimore, Williams and Wilkins, 1973, pp 453-72
12. Rowland LP: Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve 1980;3:3-20
13. Carnwath JW, Shotton DM: Muscular dystrophy in the mdx mouse: Histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 1987;80:39-54
14. Minetti C, Ricci E, Bonilla E: Progressive depletion of fast alpha-actininpositive muscle fibers in Duchenne muscular dystrophy. Neurology 1991;41:1977-81
15. Tidball JG, Albrecht DE, Lokensgard BE, et al: Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 1995;108:2197-204
16. Sandri M, Carraro U, Podhorska-Okolov M, et al: Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 1995;373:291-5
17. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine. New York, Oxford University Press, 1999
18. Halliwell B, Gutteridge JM: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990;186:1-85
19. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol 1996;271:C1424-37
20. Irintchev A, Wernig A: Muscle damage and repair in voluntarily running mice: Strain and muscle differences. Cell Tissue Res 1987;249:509-21
21. Hikida RS, Staron RS, Hagerman FC, et al: Muscle fiber necrosis associated with human marathon runners. J Neurol Sci 1983;59:185-203
22. Davies KJ, Quintanilha AT, Brooks GA, Packer L: Free radicals and tissue damage produced by exercise. Biochem Biophys Res Commun 1982;107:1198-205
23. Pyne DB: Exercise-induced muscle damage and inflammation: A review. Aust J Sci Med Sport 1994;26:49-58
24. Powers SK, Ji LL, Leeuwenburgh C: Exercise training-induced alterations in skeletal muscle antioxidant capacity: A brief review. Med Sci Sports Exerc 1999;31:987-97
25. Haycock JW, Jones P, Harris JB, et al: Differential susceptibility of human skeletal muscle proteins to free radical induced oxidative damage: A histochemical, immunocytochemical and electron microscopical study in vitro. Acta Neuropathol 1996;92:331-40
26. 2-activated metmyoglobin and other proteins. Free Radic Biol Med 1997;23:754-61
27. Murphy ME, Kehrer JP: Oxidative stress and muscular dystrophy. Chem Biol Interact 1989;69:101-73
28. Kakulas BA, Adams RD: Principles of myopathology as illustrated in the nutritional myopathy of the Rottnest quokka (Setonix brachyurus). Ann NY Acad Sci 1966;138:90-101
29. Bradley R, Fell BF: Myopathies in animals, in Walton JN (ed): Disorders of Voluntary Muscle. London, Churchill Livingston, 1980, pp 824-72
30. Hadlow WJ: Myopathies in animals, in Pearson CM, Mostofi FK (eds): The Striated Muscle, chapter 18. Baltimore, Williams and Wilkins, 1973
31. Lazaro RP, Dentinger MP, Rodichok LD, et al: Muscle pathology in Bassen-Kornzweig syndrome and vitamin E deficiency. Am J Clin Pathol 1986;86:378-87
32. Tomasi LG: Reversibility of human myopathy caused by vitamin E deficiency. Neurology 1979;29:1182-6
33. Salminen A, Kainulainen H, Arstila AU, et al: Vitamin E deficiency and the susceptibility to lipid peroxidation of mouse cardiac and skeletal muscles. Acta Physiol Scand 1984;122:565-70
34. Elias EA, Meijer AE: The increase in activity of the NADPH-regenerating enzymes of the pentose phosphate pathway in vitamin E deficiency induced myopathy in rabbits: A histochemical and biochemical study. Cell Mol Biol 1983;29:27-37
35. Hull SJ, Scott ML: Studies on the changes in reduced glutathione of chick tissues during onset and regression of nutritional muscular dystrophy. J Nutr 1976;106:181-90
36. Martensson J, Meister A: Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proc Natl Acad Sci USA 1989;86:471-5
37. Anderson M: Tissue glutathione, in Greenwald RA (ed): CRC Handbook of Methods for Oxygen Radical Research. Boca Raton, CRC Press, 1985, pp 317-23
38. Meister A: Glutathione deficiency produced by inhibition of its synthesis, and its reversal: Applications in research and therapy. Pharmacol Ther 1991;51:155-94
39. Mendell JR, Engel WK, Derrer EC: Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science 1971;172:1143-5
40. Grisotto PC, dos Santos AC, Coutinho-Netto J, et al: Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res 2000;92:1-6
41. Jeroudi MO, Hartley CJ, Bolli R: Myocardial reperfusion injury: Role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol 1994;73:2B-7B
42. Saez JC, Cifuentes F, Ward PH, et al: Tourniquet shock in rats: Effects of allopurinol on biochemical changes of the gastrocnemius muscle subjected to ischemia followed by reperfusion. Biochem Med Metab Biol 1986;35:199-209
43. Bushell A, Klenerman L, Davies H, et al: Ischemia-reperfusion-induced muscle damage: Protective effect of corticosteroids and antioxidants in rabbits. Acta Orthop Scand 1996;67:393-8
44. Formigli L, Ibba ML, Tani A, et al: Vitamin E prevents neutrophil accumulation and attenuates tissue damage in ischemic-reperfused human skeletal muscle: Histol Histopathol 1997;12:663-9
45. Rando TA: Role of nitric oxide in the pathogenesis of muscular dystrophies: A "two hit" hypothesis of the cause of muscle necrosis. Microsc Res Tech 2001;55:223-5
46. Thomas GD, Sander M, Lau KS, et al: Impaired metabolic modulation of α-adrenergic vasoconstriction in dystrophindeficient skeletal muscle. Proc Natl Acad Sci USA 1998;95:15090-5
47. Sander M, Chavoshan B, Harris SA, et al: Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc Natl Acad Sci USA 2000;97:13818-23
48. Brenman JE, Chao DS, Xia H, et al: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82:743-52
49. Chang WJ, Iannaccone ST, Lau KS, et al: Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 1996;93:9142-7
50. Vihko V, Rantamaki J, Salminen A: Exhaustive physical exercise and acid hydrolase activity in mouse skeletal muscle: A histochemical study. Histochemistry 1978;57:237-49
51. Salminen A, Vihko V: Lipid peroxidation in exercise myopathy. Exp Mol Pathol 1983;38:380-8
52. Radak Z, Asano K, Inoue M, et al: Superoxide dismutase derivative reduces oxidative damage in skeletal muscle of rats during exhaustive exercise. J Appl Physiol 1995;79:129-35
53. Lew H, Pyke S, Quintanilha A: Changes in the glutathione status of plasma, liver and muscle following exhaustive exercise in rats. FEBS Lett 1985;185:262-6
54. Rando TA, Crowley RS, Carlson EJ, et al: Overexpression of copper/zinc superoxide dismutase: A novel cause of murine muscular dystrophy. Ann Neurol 1998;44:381-6
55. Rando TA, Epstein CJ: Copper/zinc superoxide dismutase: More is not necessarily better. Ann Neurol 1999;46:135-6
56. Xing J, Yu Y, Rando TA: The modulation of cellular susceptibility: Protective and destructive actions of Cu,Zn-superoxide dismutase. Neurobiol Dis 2002;10:234-46
57. Amstad P, Moret R, Cerutti P: Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem 1994;269:1606-9
58. de Haan JB, Cristiano F, Iannello R, et al: Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Hum Mol Genet 1996;5:283-92
59. Haycock JW, MacNeil S, Jones P, et al: Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport 1996;8:357-61
60. Jackson MJ, Jones DA, Edwards RH: Techniques for studying free radical damage in muscular dystrophy. Med Biol 1984;62:135-8
61. Mechler F, Imre S, Dioszeghy P: Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 1984;63:279-83
62. Kar NC, Pearson CM: Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin Chim Acta 1979;94:277-80
63. Edwards RH, Jones DA, Jackson MJ: An approach to treatment trials in muscular dystrophy with particular reference to agents influencing free radical damage. Med Biol 1984;62:143-7
64. Hauser E, Hoger H, Bittner R, et al: Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuropediatrics 1995;26:260-2
65. Omaye ST, Tappel AL: Glutathione peroxidase, glutathione reductase, and thiobarbituric acid-reactive products in muscles of chickens and mice with genetic muscular dystrophy. Life Sci 1974;15:137-45
66. Mizuno Y: Changes in superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activities and thiobarbituric acid-reactive products levels in early stages of development in dystrophic chickens. Exp Neurol 1984;84:58-73
67. Burr IM, Asayama K, Fenichel GM: Superoxide dismutases, glutathione peroxidase, and catalase in neuromuscular disease. Muscle Nerve 1987;10:150-4
68. Mizuno Y: Superoxide dismutase activity in early stages of development in normal and dystrophic chickens. Life Sci 1984;34:909-14
69. Murphy ME, Kehrer JP: Activities of antioxidant enzymes in muscle, liver and lung of chickens with inherited muscular dystrophy. Biochem Biophys Res Commun 1986;134:550-6
70. Murphy ME, Kehrer JP: Oxidation state of tissue thiol groups and content of protein carbonyl groups in chickens with inherited muscular dystrophy. Biochem J 1989;260:359-64
71. Patnode R, Bartle E, Hill EJ, et al: Enzymological studies on hereditary avian muscular dystrophy. J Biol Chem 1976;251:4468-75
72. Hooton BT, Watts DC: Levels of protein and non-protein sulphydryl groups in the skeletal muscle of normal and dystrophic Bar Harbor mice. Clin Chim Acta 1967;16:173-6
73. +) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol 2001;98:235-43
74. Spencer MJ, Tidball JG: Do immune cells promote the pathology of dystrophin-deficient myopathies? Neuromuscul Disord 2001;11:556-64
75. Mizuno Y: Glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase activities in early stages of development in dystrophic chickens. J Neurol Sci 1985;68:47-60
76. Disatnik MH, Dhawan J, Yu Y, et al: Evidence of oxidative stress in mdx mouse muscle: Studies of the pre-necrotic state. J Neurol Sci 1998;161:77-84
77. Wang JF, Forst J, Schroder S, et al: Correlation of muscle fiber type measurements with clinical and molecular genetic data in Duchenne muscular dystrophy. Neuromuscul Disord 1999;9:150-8
78. Johnson MA, Sideri G, Weightman D, et al: A comparison of fibre size, fibre type constitution and spatial fibre type distribution in normal human muscle and in muscle from cases of spinal muscular atrophy and from other neuromuscular disorders. J Neurol Sci 1973;20:345-61
79. Doriguzzi C, Palmucci L, Mongini T, et al: Quantitative analysis of quadriceps muscle biopsy: Results in 7 definite and 45 possible carriers of Duchenne muscular dystrophy. J Neurol Sci 1986;72:201-9
80. Salminen A, Vihko V: Endurance training reduces the susceptibility of mouse skeletal muscle to lipid peroxidation in vitro. Acta Physiol Scand 1983;117:109-13
81. Asayama K, Dettbarn WD, Burr IM: Differential effect of denervation on freeradical scavenging enzymes in slow and fast muscle of rat. J Neurochem 1986;46:604-9
82. Austin L, Arthur H, de Niese M, et al: Micromethods in single muscle fibers: 2. Determination of glutathione reductase and glutathione peroxidase. Anal Biochem 1988;174:575-9
83. Porter JD: Extraocular muscle sparing in muscular dystrophy: A critical evaluation of potential protective mechanisms. Neuromuscul Disord 1998;8:198-203
84. Boland B, Himpens B, Denef JF, et al: Site-dependent pathological differences in smooth muscles and skeletal muscles of the adult mdx mouse. Muscle Nerve 1995;18:649-57
85. Ragusa RJ, Chow CK, Porter JD: Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul Disord 1997;7:379-86
86. Ragusa RJ, Chow CK, St. Clair DK, et al: Extraocular, limb and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice. J Neurol Sci 1996;139:180-6
87. Gohil K, Packer L, de Lumen B, et al: Vitamin E deficiency and vitamin C supplements: Exercise and mitochondrial oxidation. J Appl Physiol 1986;60:1986-91
88. Chou T, Hill EJ, Bartle E, et al: Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy. J Clin Invest 1975;56:842-9
89. Serafin WE, Dement SH, Brandon S, et al: Interactions of vitamin E and penicillamine in the treatment of hereditary avian muscular dystrophy. Muscle Nerve 1987;10:685-97
90. Bornman L, Rossouw H, Gericke GS, et al: Effects of iron deprivation on the pathology and stress protein expression in murine X-linked muscular dystrophy. Biochem Pharmacol 1998;56:751-7
91. Hubner C, Lehr HA, Bodlaj R, et al: Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy. Pediatr Res 1996;40:444-9
92. Walton JN, Nattrass FJ: On the classification, natural history, and treatment of the myopathies. Brain 1954;77:169-231
93. Stern LZ, Ringel SP, Ziter FA, et al: Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol 1982;39:342-6
94. Roelofs RI, de Arango GS, Law PK, et al: Treatment of Duchenne's muscular dystrophy with penicillamine: Results of a double-blind trial. Arch Neurol 1979;36:266-8
95. Fenichel GM, Brooke MH, Griggs RC, et al: Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E. Muscle Nerve 1988;11:1164-8
96. Brooke MH, Griggs RC, Mendell JR, et al: Clinical trial in Duchenne dystrophy: I. The design of the protocol. Muscle Nerve 1981;4:186-97
97. Brooke MH, Fenichel GM, Griggs RC, et al: Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103
98. Dubowitz V, Heckmatt J: Management of muscular dystrophy: Pharmacological and physical aspects. Br Med Bull 1980;36:139-44
99. Rando TA, Disatnik MH, Yu Y, et al: Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscul Disord 1998;8:14-21
100. Disatnik MH, Chamberlain JS, Rando TA: Dystrophin mutations predict cellular susceptibility to oxidative stress. Muscle Nerve 2000;23:784-92
101. Langenbach KJ, Rando TA: Inhibition of dystroglycan binding to laminin disrupts the p13K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 2002 (in press)
102. Thornalley PJ, Vasak M: Possible role for metallothionein in protection against radiation-induced oxidative stress: Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 1985;827:36-44
103. i regulation in apoptosis, oncosis, and necrosis. Biochim Biophys Acta 1996;1313:173-8
104. 2+ fit in? Cell Calcium 1998;24:387-403
105. Lipton SA, Nicotera P: Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium 1998;23:165-71
106. Hardiman O: Dystrophin deficiency, altered cell signalling and fibre hypertrophy. Neuromuscul Disord 1994;4:305-15
107. Spencer MJ, Croall DE, Tidball JG: Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 1995;270:10909-14
108. Alderton JM, Steinhardt RA: How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 2000;10:268-72
109. 2+ metabolism. Med Hypotheses 1989;29:187-93